Acryl Inc.

Acryl Inc.

KKRX:0007C0
13,990.00
KRW
-670.00
(-4.57%)
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

CEO
Wae-Jin Park
Sector
Technology services
Industry
Packaged software
Address
Seoul South Korea
IPO Date
Dec 16, 2025
Website
acryl.ai
Business
Acryl Inc. is a South Korea-based artificial intelligence (AI) transformation and infrastructure software company. Founded in 2011 and headquartered in Seoul, South Korea, the company specializes in enterprise AI operations (MLOps, LLMOps, and AgentOps), domain-specific foundation models, healthcare data intelligence, and physical AI platforms. Acryl develops comprehensive software architectures and integration services designed to accelerate AI deployment across medical, educational, public, and industrial sectors. The company delivers its technology through specialized product suites and software platforms, including Jonathan, an enterprise AI lifecycle management and AgentOps platform that governs model development, distributed training, validation, deployment, and continuous monitoring; Jonathan.H, a healthcare-focused AgentOps platform engineered to oversee clinical AI agents within secure on-premises environments; GPUBASE, a GPU virtualization and cluster orchestration solution that optimizes hardware utilization and computational efficiency for AI workloads; ALLM.H (Areum.H), a proprietary on-premises large language model specialized in clinical terminology, diagnostic context, and medical question-answering; NADIA (including NADIA-ANE), a semantic data abstraction and electronic medical record (EMR) integration platform that standardizes hospital databases for AI interoperability without legacy system displacement; Jonathan PAI, a physical AI middleware platform that coordinates and controls heterogeneous robotic systems; and AI Transformation (AX) Consulting Services, providing emotion computing, multimodal algorithm development, and sovereign AI infrastructure design. Acryl targets general and university hospitals, healthcare networks, enterprise cloud operators, educational service providers, and government research entities across South Korea and global markets, with expanding operations in Central Asia. In recent developments, Acryl completed its initial public offering on the KOSDAQ market (KRX:0007C0) in December 2025 under the technology growth listing track. The company has expanded its commercial reach through strategic alliances, including a partnership with MegazoneCloud to deliver end-to-end GPU infrastructure and global enterprise AX services, a consortium agreement with edutech providers to build intelligent education platforms, and technical collaboration with MangoBoost to advance domestic NPU and DPU accelerator integration. Globally, Acryl secured strategic healthcare agreements with Uzbekistan's State Health Insurance Fund and UZINFOCOM to establish regional AI data centers and digital healthcare systems, complementing the ongoing domestic deployment of its integrated AI-Native Healthcare Stack.